Labetalol in severe and resistant hypertension - Wikidata - wikimedia - TriplyDB

Labetalol in severe and resistant hypertension

Labetalol in severe and resistant hypertension

http://www.wikidata.org/entity/Q42034900

about

Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.Magnitude and mechanisms of the antihypertensive action of labetalol, including ambulatory assessment.

P2860

Q34517987-6914036E-F009-4AD4-B81D-C224406B9641 Q43261907-148DCE3C-F765-4078-9C47-6FD55C62B274

P2860

Labetalol in severe and resistant hypertension

http://www.wikidata.org/entity/Q42034900

description

1979 nî lūn-bûn

@nan

1979年の論文

@ja

1979年論文

@yue

1979年論文

@zh-hant

1979年論文

@zh-hk

1979年論文

@zh-mo

1979年論文

@zh-tw

1979年论文

@wuu

1979年论文

@zh

1979年论文

@zh-cn

name

Labetalol in severe and resistant hypertension

@en

Labetalol in severe and resistant hypertension

@nl

type

label

Labetalol in severe and resistant hypertension

@en

Labetalol in severe and resistant hypertension

@nl

prefLabel

Labetalol in severe and resistant hypertension

@en

Labetalol in severe and resistant hypertension

@nl

P1433

Q42034900-D4DEEF4A-DF25-42F5-A69D-FDFB196CFCE1

P1476

Q42034900-D24E06EA-1B8F-4ABE-8FEC-A8C4E63E2E37

P2093

Q42034900-2E5FCFCF-EC0E-40D7-B8A0-2C8CFB460E1C

Q42034900-38F9343E-7B37-426C-B775-DAEAEF64BF3C

Q42034900-3CECFA1E-77AA-4BD9-910E-8C1E45DA3F68

P2860

Q42034900-1808B9B1-B0AD-4473-8BAF-62FC3C091C67

Q42034900-2685FAF7-F461-49CF-B730-FF0230E332A3

Q42034900-2DDADB2E-CD92-445F-B92C-6BA9A7C3F6C0

Q42034900-5DB2418C-D5B8-4FD7-A3AD-7171C976529A

Q42034900-62E23622-3DF9-410E-8369-D8CBA4E63012

Q42034900-855195FD-6646-4491-82B5-20EA95ABA881

Q42034900-A29753AE-553F-42D6-9CAE-E53D64B53E55

Q42034900-A48C8C06-A14E-44E3-B499-B92B05637AED

Q42034900-C93C94C7-835D-4188-982B-6A26B8BE22D6

P304

Q42034900-A122AF59-58B9-4614-AF9C-3E42C3E19C4D

P31

Q42034900-6A257BBE-358A-48FF-8730-4AA4CEFF35B9

P407

Q42034900-1230EC95-3472-4C22-BF5D-BFC5E9981FED

P433

Q42034900-911BEECB-CE8A-4D46-A5AD-0E70EB57FA00

P478

Q42034900-F1EBF5FF-24FD-4BE7-9C07-440E6E621C52

P577

Q42034900-1CFE9FC6-2D44-4C7D-985E-D6B150C3B956

P698

Q42034900-E47C0697-E29F-469A-98D3-0719E32A9912

P932

Q42034900-702B0331-6D00-4D65-BFD9-6154D3BB28C7

P1433

British Journal of Clinical Pharmacology

P1476

Labetalol in severe and resistant hypertension

@en

P2093

Murphy MJ

http://www.w3.org/2001/XMLSchema#string

Parsons V

http://www.w3.org/2001/XMLSchema#string

Williams LC

http://www.w3.org/2001/XMLSchema#string

P2860

Labetalol in resistant hypertension

Labetalol in the treatment of patients with hypertension and renal function impairment.

Rapid identification of patients with essential hypertension sensitive to acebutolol (a new cardioselective beta-blocker).

Different antihypertensive effect of beta-blocking drugs in low and normal-high renin hypertension.

Labetalol in long-term treatment of hypertension.

Controlled comparison of labetalol and propranolol in the management of severe hypertension.

Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension.

Renin reactivity as a determinant of responsiveness to antihypertensive treatment.

Beta-blockers and plasma renin activity in hypertension.

P304

143S-147S

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

Suppl 2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

1979-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

526395

http://www.w3.org/2001/XMLSchema#string

P932

1429737

http://www.w3.org/2001/XMLSchema#string